Area of presentation – Final sterilization for pharmaceutical applications: development of innovative customized solutions
Speaker: Dr. Bart Croonenborghs - Technical Director Irradiation
- What are the current global trends driving the pharmaceutical sector you are working in? How does your company respond to those trends?
Pharma companies are increasingly exploring terminal sterilization as an alternative to, or adjunct to, Aseptic Processing. Sterigenics provides terminal sterilization solutions for Pharma and other ‘sensitive’ products using customized processing techniques
2. What are the top challenges faced by the pharmaceutical sector you represent at this moment? How does your company deal with these challenges?
Challenges are driven by the sensitivity of the products to the various sterilization modalities. Sterigenics is able to design test studies to identify the most appropriate sterilization technology, apply very narrow processing parameter tolerances and provide customized terminal sterilization solutions for Pharma and other ‘sensitive’ products. This customization includes optimizing product presentation and management of environmental conditions during sterilization which can mitigate degradation of pharmaceuticals and materials to provide precise and capable routine terminal sterilization processes.
3. What topic are you presenting at the Pharma Insight Briefings and why is this subject so important to the market at this time?
Describing the approach to custom sterilization solutions which have been designed and provided to pharma companies with an optimum and robust process for their products.
4. What can attendees to your session expect to gain and which challenges does this content address? Why should they include your presentation in their agenda?
An appreciation of the different options that are available for the terminal sterilization of their products